Effect of Curcumin on Pediatric Intractable Epilepsy
Iranian Journal of Child Neurology,
Vol. 16 No. 3 (2022),
Epilepsy is the most prevalent chronic neurologic disorder in children. One-third of patients with epilepsy do not respond to antiepileptic drugs. This condition is known as intractable epilepsy. Previous studies have shown the beneficial effects of curcumin in the treatment of epilepsy. There are no randomized controlled clinical
trials assessing the use of curcumin in epilepsy. This study aimed to evaluate the effects of nanomicelle curcumin on intractable pediatric epilepsy.
Materials & Methods
This double-blinded randomized crossover clinical trial was performed by a consecutive sampling to select 22 patients with intractable epilepsy divided into two groups. Patients received a daily dose of 4 mg/kg of curcumin or placebo as add-on therapy for 4 weeks. After a 2-week washout period, the treatment was replaced, and the new treatment was given for another 4 weeks. The SPSS software version 16 was used for statistical analysis. The study was approved by the Ethics Committee of Mashhad University of Medical Sciences, Iran
A total of 22 children were enrolled in this study, 11 of which were boys. The mean age of the patients was 4.28±5 years. A female patient taking a placebo was excluded in the first week of the trial due to parental dissatisfaction. The most common type of seizure among our patients was a generalized myoclonic seizure (42.9%). The mean number of seizure attacks among the subjects was 68.76±69.26 preintervention and 39.85±39.41at the end of the intervention, which represents a statistically significant difference (P=0.01).
Nanomicelle curcumin reduced the number of seizures significantly. Our results imply that curcumin treatment can help treat patients wit intractable pediatric epilepsy.
- Myoclonic seizures
How to Cite
Ezz H, Khadrawy Y, Noor N. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochemical research. 2011;36(11):2195.
Gupta Y, Briyal S, Sharma M. Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian journal of physiology and pharmacology. 2009;53(1):39.
Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383-98.
Jyoti A, Sethi P, Sharma D. Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy & Behavior. 2009;14(2):300-8.
Mehla J, Reeta K, Gupta P, Gupta YK. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life sciences. 2010;87(19):596-603.
Noor NA, Ezz HSA, Faraag AR, Khadrawy YA. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy & Behavior. 2012;24(2):199-206.
Orellana-Paucar AM, Serruys A-SK, Afrikanova T, Maes J, De Borggraeve W, Alen J, et al. Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models. Epilepsy & Behavior. 2012;24(1):14-22.
Singh AK, Jiang Y, Benlhabib E, Gupta S. Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water. Journal of medicinal food. 2007;10(3):526-42.
Lagunju I. Complementary and alternative medicines use in children with epilepsy in Ibadan, Nigeria. African journal of medicine and medical sciences. 2013;42(1):15-23.
Hino H, Takahashi H, Suzuki Y, Tanaka J, Ishii E, Fukuda M. Anticonvulsive effect of paeoniflorin on experimental febrile seizures in immature rats: Possible application for febrile seizures in children. PLoS One. 2012;7(8):e42920.
Mitchell JW, Seri S, Cavanna AE. Pharmacotherapeutic and non-pharmacological options for refractory and difficult-to-treat seizures. Journal of central nervous system disease. 2012;4.
Rahimi HR, Kazemi Oskuee R. Curcumin From Traditional Iranian Medicine to Molecular Medicine. Razavi Int J Med. 2014;2(2):3-4.
Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Ghayour Mobarhan M, et al. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna journal of phytomedicine. 2016;6(5):567-77.
Bozhinova S, Bozhinov P. Using ultrogestan for the treatment of spontaneous abortions and complications of climax in women with epilepsy. Akusherstvo i ginekologiia. 2004;44(6):20-4.
Smithson KW, Millar DB, Jacobs LR, Gray GM. Intestinal diffusion barrier: unstirred water layer or membrane surface mucous coat? Science. 1981;214(4526):1241-4.
Howles PN. Cholesterol absorption and metabolism. Mouse Models for Drug Discovery: Methods and Protocols. 2010:157-79.
Rahimi HR, Jaafari MR, Mohammadpour AH, Abnous K, Ghayour Mobarhan M, Ramezanzadeh E, et al. Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease. Asia Pacific Journal of Medical Toxicology. 2015;4(1):25-30.
Abdollahi Fard M, Shojaii A. Efficacy of Iranian traditional medicine in the treatment of epilepsy. BioMed research international. 2013;2013.
Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes & nutrition. 2011;6(2):93-108.
Qureshi IA, Mehler MF. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiology of disease. 2010;39(1):53-60.
Agarwal NB, Jain S, Nagpal D, Agarwal NK, Mediratta PK, Sharma KK. Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundamental & clinical pharmacology. 2013;27(2):169-72.
Li Q, Chen XY, He L, Zhou D. WITHDRAWN: Traditional Chinese medicine for epilepsy. Cochrane Database Syst Rev. 2014(3):CD006454.
Akula KK, Kulkarni SK. Effect of curcumin against pentylenetetrazol-induced seizure threshold in mice: possible involvement of adenosine A1 receptors. Phytother Res. 2014;28(5):714-21.
Zaky A, Mahmoud M, Awad D, El Sabaa BM, Kandeel KM, Bassiouny AR. Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats. Frontiers in cellular neuroscience. 2014;8.
Ezz HSA, Khadrawy YA, Noor NA. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochemical research. 2011;36(11):2195.
Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei S, Ghamarchehreh M, et al. Adjunctive therapy with curcumin for peptic ulcer: a randomized controlled trial. Drug research. 2016;66(08):444-8.
- Abstract Viewed: 61 times
- pdf Downloaded: 0 times